Century Therapeutics, Inc. (IPSC) vs Nautilus Biotechnology, Inc. (NAUT)
- Century Therapeutics, Inc. IPSC 1.37 −8.67%
- Nautilus Biotechnology, Inc. NAUT 2.06 −4.63%
Century Therapeutics, Inc. and Nautilus Biotechnology, Inc. are both Biotechnology companies. Century Therapeutics, Inc. and Nautilus Biotechnology, Inc. are of similar size ($274.9M and $271.6M). Across the 10 metrics below, Nautilus Biotechnology, Inc. leads on 6 and Century Therapeutics, Inc. on 4.
Valuation
Profitability
| Metric | IPSC | NAUT | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (49.65%) | (36.21%) | (56.36%) |
| Return on assets | (38.41%) | (30.00%) | (48.04%) |
| Return on invested capital | (64.92%) | (83.32%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack